The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses’ Health Study
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses’ Health Study
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 129, Issue 1, Pages 175-184
Publisher
Springer Nature
Online
2011-03-08
DOI
10.1007/s10549-011-1432-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study
- (2010) Shaheenah Dawood et al. BREAST CANCER RESEARCH AND TREATMENT
- Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up
- (2010) Lisa Rydén et al. BREAST CANCER RESEARCH AND TREATMENT
- Aspirin Intake and Survival After Breast Cancer
- (2010) Michelle D. Holmes et al. JOURNAL OF CLINICAL ONCOLOGY
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
- (2010) Fiona M. Blows et al. PLOS MEDICINE
- The role of VEGF in triple-negative breast cancer: where do we go from here?
- (2009) S. F. Dent ANNALS OF ONCOLOGY
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor
- (2009) B. Linderholm et al. MEDICAL ONCOLOGY
- Estrogen receptor-β expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
- (2009) Jonathan D Marotti et al. MODERN PATHOLOGY
- Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts
- (2009) C. L. Roland et al. MOLECULAR CANCER THERAPEUTICS
- Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression
- (2009) M. R. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer
- (2008) Barbro K. Linderholm et al. BREAST
- Vascular Endothelial Growth Factor Reduces Tamoxifen Efficacy and Promotes Metastatic Colonization and Desmoplasia in Breast Tumors
- (2008) Z. Qu et al. CANCER RESEARCH
- Prognostic Effect of Basal-Like Breast Cancers Is Time Dependent: Evidence from Tissue Microarray Studies on a Lymph Node-Negative Cohort
- (2008) A. M. Mulligan et al. CLINICAL CANCER RESEARCH
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer
- (2008) Sriparna Ghosh et al. HUMAN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started